- Cannabis space facing “critical moment” as consumers seek proven consistency
- Pac Roots partner, business model assists in commitment to deliver “predictable, reliable product”
- Pac Roots ideally positioned to preserve excellence of its elite strains while also introducing highest quality of new strains
The cannabis industry has reached a crossroads of sorts, according to a recent “New York Times” article, as the substance has become increasingly mainstream. While welcome, the popularity of cannabis presents a challenge that companies such as Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) are eager to meet.
“The cannabis business, then, has arrived at a critical moment,” states the article, which is aptly titled “Cannabis Scientists Are Chasing the Perfect High” (https://cnw.fm/8hGYB). “Now that pot has become something like a regular consumer product, customers are increasingly seeking the same ‘proven consistency’ they expect from potato chips and soap.
“The financial stakes are clear,” the article continues. “Despite lingering prohibitions in 17 states, legal cannabis is already an $8 billion industry in the United States. Domestic sales of alcohol, humankind’s other favorite intoxicant, topped $200 billion last year. But to make cannabis as popular as booze requires solving that original problem: It’s hard to imagine millions of people becoming new recreational users without being able to promise them that the product they’re spending money on — the average purchase at INSA is around $90 — will give them the effect they want.”
That quest for consistency and customization is one that Pac Roots is well equipped to pursue — and achieve. The Canadian company is committed to producing premium-quality strains and products by leveraging a genetics-focused approach. The company’s unique partnership with Phenome One, recognized as one of Canada’s largest live genetic libraries, allows Pac Roots to focus on selective breeding and preservation (https://cnw.fm/Y3mGQ). As part of the partnership, PacRoots Cannabis has access to Phenome One’s proprietary database of more 350 unique, live cannabis strains, which have been carefully field tested and artificially selected over three decades of research.
That key partnership, which enables Pac Roots to optimize the genetic makeup of its cannabis plants as well as develop unique strains featuring a variety of beneficial characteristics, established the company as a frontrunner in the search for what the “New York Times” called an elusive prize: “a predictable, reliable product.” With Phenome One in its corner, along with its existing infrastructure, equipment, and access to land as well as aligned brands, Pac Roots is ideally positioned to preserve the excellence of its elite strains while also introducing the highest quality of new strains.
“Many strive to be the largest cannabis grower,” the company proclaims, “but we believe that the quality of the cannabis you consume is paramount. Customers are extremely educated and mindful about the foods and drinks they intake. The demand for premium products has never been higher, and Pac Roots is well-positioned to be a leader in the premium cannabis space.”
Pac Roots Cannabis is a Canadian company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach. The company’s commitment to quality and excellence is evident in its mantra of “quality over quantity” (https://cnw.fm/Ahlk4). The company is focused on elite genetic development and maximizes the quality of its offerings by keeping yields and profit margins high.
The company also leverages key partnerships to ensure the superiority of its products. Those partnership include Phenome One, which has built one of the largest live genetic libraries in Canada with more than 350 live cultivars, and Rock Creek Farms and Speakeasy Cannabis Club, both which provide existing infrastructure, equipment and access to land.
For more information, visit the company’s website at www.PacRoots.ca.
NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
